OTCPK:CLVLF (Australia)  
Clinuvel Pharmaceuticals Ltd logo

Clinuvel Pharmaceuticals Ltd

$ 12.00 0 (0%) 10:08 PM EST
P/E:
45.88
P/B:
7.28
Market Cap:
$ 673.02M
Enterprise V:
$ 578.73M
Volume:
-
Avg Vol (2M):
732.00
Also Trade In:
Volume:
-
Market Cap $:
673.02M
PE Ratio:
45.88
Avg Vol (2-Month):
732.00
Enterprise Value $:
578.73M
PB Ratio:
7.28
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Clinuvel Pharmaceuticals Ltd is an Australia-based biopharmaceutical company. It is engaged in developing drugs for the treatment of genetic and vascular disorders. Its principal compound, SCENESSE is a drug for erythropoietic protoporphyria. Its pioneering work aims at preventing the symptoms of skin diseases related to exposure to harmful UV radiation and at repigmentation of the skin due to several depigmentation disorders. Geographically, it derives a majority of its revenue from Europe and the USA.

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Gurus Latest Trades with OTCPK:CLVLF

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 46.495
EPS (TTM) ($) 0.285
Beta 1.05
Volatility % 44.9
14-Day RSI 40.93
14-Day ATR ($) 0.139398
20-Day SMA ($) 12.4635
12-1 Month Momentum % -39.33
52-Week Range ($) 9.5 - 20.6425
Shares Outstanding (Mil) 49.41

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Clinuvel Pharmaceuticals Ltd Filings

Document Form Filing Date
No Filing Data

Clinuvel Pharmaceuticals Ltd Analysis

Share your research

Headlines

See More
No news.